by clearskymd | Jan 21, 2019 | Company News
ClearSky Medical Diagnostic’s research workshop on improving machine learning was a success. Attended by our clinical partners at Leeds General Infirmary in December, including neurologists and specialists in neurodegenerative diseases. We organised the workshop to... 
by clearskymd | Jan 17, 2019 | Company News
We’re delighted to welcome Xiang Li to the ClearSky Medical Diagnostics team – she joined us on a 3-month internship in December. Xiang will be based at the ClearSky MD’s headquarters at the University of York. My name is Xiang Li and I recently finished my MSc in... 
by clearskymd | Dec 18, 2018 | Company News
Professor Stephen Smith travelled to Bangalore in November to co-lead a tutorial at the 2018 IEEE Symposium Series on Computational Intelligence (IEEE SSCI 2018). IEEE SSCI 2018 is an annual international conference organised by the IEEE Computational Intelligence... 
by clearskymd | Sep 28, 2018 | Company News, Parkinson's
Large scale research in China backs up the validity and high accuracy of PD-Monitor for Parkinson’s diagnosis ClearSky’s PD-Monitor can be used to confirm the diagnosis of Parkinson’s in very early stages based on the presence of bradykinesia in the... 
by clearskymd | Jul 16, 2018 | Company News
Members of the ClearSky team have been selected as finalists in the Human-Competitive Awards (Humies), which take place at GECCO 2018 in Japan this week. The Humies Awards recognise work that has not just solved some problem via techniques from evolutionary... 
by clearskymd | Jun 20, 2018 | Company News
ClearSky’s PD-Monitor has been used in a nationwide study to investigate whether statins are effective in slowing the progress of Parkinson’s. Statins, such as Simvastatin, are a group of medicines that are currently prescribed to lower cholesterol in the blood....
Recent Comments